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ABSTRACT: Background - Uncontrolled atrial fibrillation (AF) results in complex changes in the
cardiomyocyte  electrical  and  contractile  functioning  that  promote  atrial  remodeling  and  the
continuation of AF. Recently there has been a growing interest in understanding the role of heat shock
proteins (HSPs), which are cytoprotective molecular chaperones, in the pathophysiology of AF. Several
groups have examined HSP expression in patients with AF but have yielded mixed results. To allow for
better consistency and reproducibility between subjects, we utilized canine models to reproduce AF-
promoting conditions to better investigate the role of HSPs in the pathophysiology of AF. Methods - AF
promoting conditions were simulated in canine models with fifteen adult mongrel dogs (20.6 to 36.0 kg)
divided into three groups: (1) Control (n=5), (2) two week ventricular tachypacing (VTP) induced
congestive heart failure (CHF) (n=5), and (3) one week atrial tachypacying (ATP) (n=5). Quick frozen
right atrial free wall tissue samples were used for protein isolation and were analyzed via Western
blotting with data was expressed as a relative ratio and were analyzed using a two-tailed, unpaired t-
test and significance was set at p < 0.05. The expression levels of HSP 90, 70, and 25 were studied along
with the phosphorylation status of HSP27 at serine-78. Results -We first examined the effects of the ATP
and CHF heart models on the expression of a select group of HSPs via Western Blot. We found that
there was no significant difference in levels of expression of HSP 90, 70, or 25 when either ATP or CHF
models  were  compared  to  control  canines. The  phosphorylation  status  of  HSP27  was  significantly
decreased in the CHF canine model when compared to control (p < 0.0111) and it tended towards a
decrease in the ATP canine model when compared to control (p=0.0923). Conclusion - This study
showed  that  even  though  the  expression  levels  of  HSPs  may  remain  constant,  there  are  protein
phosphorylation and dephosphorylation events that occur in AF that may have important consequences
in its pathophysiology. It is therefore necessary to investigate the full scale of HSP modifications during
AF and AF-promoting conditions.
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INTRODUCTION
Atrial fibrillation (AF) is the most common cardiac
arrhythmia  found  in  the  general  population  and  is
associated with both morbidity and mortality (1). Poorly
controlled AF can result in many complications such as
stroke  and  tachycardia-induced  cardiomyopathy,  and
according  to  the  Framingham  Heart  Study,  AF  is
associated with a decrease in overall survival (2). The
maintenance of AF is promoted by AF-induced atrial
remodeling,  which  involves  complex  changes  in  the
cardiomyocyte  electrical  and  contractile  function  (3).
The proteins involved in AF-induced atrial remodeling,
and  their  respective  molecular  mechanisms  are
currently  being  delineated.  One  group  of  proteins,
known as the heat shock proteins (HSPs), are molecular
chaperons  that  are  induced  by  many  physiological
stressors, and are known to convey a protective function
in cells during times of stress (4). The HSPs are proteins
of interest that play a key cytoprotective role in AF and
may represent a novel molecular target in AF therapy.
However, the underlying mechanism of their action in
AF pathogenesis remains unclear.
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There has been growing interest in understanding the
role of HSPs in the pathophysiology of AF. Recently,
several  groups  have  examined  HSP  expression  in
patients with AF, relative to those in sinus rhythm (SR),
but these studies yielded mixed results. Although HSP
expression was often found to be increased in patients
with AF, there has been no clear consensus as to which
groups of HSPs (HSP90, HSP70, HSP60, HSP27) are
most effected (5-7). A more recent study indicated that
ischemia-induced AF is prevented by the induction of
exogenous HSP, and suggested that atrial ischemia in
itself may activate HSP production (8). 
Patients  with  AF  experience  a  wide  variation  of
severity  and  duration  of  symptoms.  This  degree  of
variability  between  subjects  makes  previous  studies
with  only  a  limited  number  of  human  subjects
unreliable and therefore it offers a possible explanation
for why there has been no agreement in which HSPs are
involved in the pathophysiology of AF. To allow for a
better understanding of the pathophysiology of AF, it is
therefore necessary to utilize an animal model which
has the added benefit by allowing for control over the
AF promoting conditions. In this study, AF-promoting
conditions  were  simulated  in  canine  models  by  two
week ventricular tachypacing (VTP), which is a canine
model of congestive heart failure (CHF), and by atrial
tachypacing  (ATP).  Both  atrial  and  ventricular
tachypacying in canines is known to produce conditions
conducive to atrial remodeling similar to that found in
AF.  In  this  current  study  the  expression  of  HSP70,
HSP90, and HSP25 were analyzed in right atrial tissue
samples. Given that the phosphorylation status of small
HSPs,  such  as  HSP27  and  HSP25  (HSP25  is  an
ortholog of HSP27), is crucial in the regulation of their
function and cellular localization, the phosphorylation
status of HSP27 was evaluated in both AF-promoting
canine models as a means to further elucidate the role of
HSPs in AF cytoprotection in vivo. 
METHODS
Animal Model and Cardiomyocyte Isolation
The animal model was prepared as previously
described (9). In brief, fifteen adult mongrel dogs (20.6
to 36.0 kg) were divided into three groups: (1) Control
(n=5),  (2)  two  week  ventricular  tachypacing  (VTP)
induced congestive heart failure (CHF) (n=5), and (3)
one week atrial tachypacying (ATP) (n=5). CHF dogs
had unipolar pacing leads inserted fluoroscopically into
the right ventricular apex, which were programmed at
240 bpm for 2 weeks. ATP remodeling was induced by
1 week of right atrial pacing at 400 bpm after AV node
ablation as previously described (10). The experimental
protocols were reviewed and approved by the Montreal
Heart Institute Animal Research Ethics Committee.
On the final day of study the dogs were anesthetized
with morphine (2 mg/kg SC) and alpha-chloralose (120
mg/kg  IV,  followed  by  29.25  mg/kg  per  hour)  and
mechanically  ventilated.  Right  and  left  atria
preparations were dissected and fast-frozen (9). RA and
LA cells were stored separately in Tyrode solution with
200 ʼmol/L Ca2+. In this study, right atrial samples
were used.
Protein Isolation
Quick frozen right atrial free wall tissue samples were
used for protein isolation. Tissue samples were placed
in  Ripa  buffer  (1%  IGEPAL,  0.5%  Sodium
deoxycholate,  0.1%  SDS,  and  Beta-mercaptoethanol)
containing protease inhibitors (Complete mini, EDTA
free protease inhibitor cocktail tablets from ROCHE)
and  phosphatase  inhibitors  (sodium  fluoride,  beta-
glycerol phosphate, sodium orthovanadate, microcystin,
EGTA, and EDTA). Samples were homogenized and
placed on ice for 20 minutes and centrifuged at 3000
rpm for 10mins at 4ﾰC. The resultant supernatant was
collected and centrifuged at 15000 rpm for 15 minutes
at 4ﾰC. The final supernatant was collected and lysate
concentrations  were  quantified  using  the  Bradford
Assay.
Western Blot Analysis
Tissue  extracts  (30  ʼg)  were  separated  on  a  10%
SDS-polyacrylamide gel. Proteins were transferred to a
polyvinylidene  difluoride  membrane  (Millipore,
Bedford,  MA)  and  blocked  for  1  hour  at  room
temperature using 5% milk in TBST. Membranes were
incubated with primary antibody (1:2000; anti- HSP25,
HSP70, HSP90, P-ser78 HSP27 from StressGen) over
night at 4ﾰC. The blots were then washed 3 times for 15
minutes with TTBS and then incubated for 1h with the
appropriate  HRP-conjugated  antibody  (1:10000;  anti-
rabbit  and  anti-mouse).  The  blots  were  washed  four
times  with  TTBS.  Immuno-complexes  were  detected
using  ECL  and  visualized  on  film.  Bands  were
quantified  via  densitometry  and  standardized  to
GAPDH. 
Statistical Analysis
Data  are  expressed  as  a  relative  ratio  and  were
analyzed  using  a  two-tailed,  unpaired  t-test  and
significance was set at p < 0.05. 
RESUlTS
Relationship between ATP and CHF Canine Models
and HSP Expression
Canine  models  were  utilized  to  provide  a  greater
degree  of  standardization  and  reproducibility  not
possible when studying tissue samples from patients.
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models on the expression of a select group of HSPs via
Western Blot. With an n=5 for each of the control, ATP
and  CHF  groups  we  found  there  was  no  significant
change in expression levels of HSP25 in Control vs.
CHF and Control vs. ATP (Figure 1). We also examined
expression levels of other HSPs which have previously
been  shown  to  be  related  with  AF.  Analysis  of
expression  levels  of  HSP70  (Figure  2)  and  HSP90
(Figure  3)  again  showed  no  significant  difference
between the experimental dogs (ATP and CHF) and the
control dogs. 
HSP27 Phosphorylation Status is Reduced by 
ATP and CHF
HSP27 has three known phosphorylation sites (ser15,
ser78, and ser82) (11). The phosphorylation status of
HSP27 is known have effects on cellular localization
along  with  regulating  its  function  as  a  molecular
chaperone. To determine whether the phosphorylation
status of HSP27 is affected in ATP and/or CHF canine
models  we  examined  the  phosphorylation  state  on
serine-78,  which  is  known  to  be  an  important
phosphorylation  site  in  determining  HSP27’s  cellular
location  (11).  Phosphorylation  was  analyzed  via
Western blot with control, ATP, and CHF on the same
15 well gel with n=5 for each group. As seen in Figure
4,  there  was  a  trend  towards  decreased  HSP27
phosphorylation  in  ATP,  relative  to  the  controls,
although  it  failed  to  reach  significance  (p=0.0923).
However,  The  CHF  group,  however,  showed  a
significant decrease in the phosphorylation of HSP27
compared to the controls (p < 0.0111). 
DISCUSSION  
To date the effects of AF-promoting conditions on
HSP27  phosphorylation  status  has  not  been  widely
studied.  We  demonstrated  in  this  study  that  the
phosphorylation status of HSP27 is decreased in both
the CHF and ATP canine models of AF. It is known that
the phosphorylation of two serine residues (ser-78 and
ser-82)  is  necessary  for  HSP27  localization  into  the
nucleus  (11).  During  conditions  of  stress,  HSP27  is
phosphorylated and translocated into the nucleus where
it  may  protect  against  DNA  damage  (11).  Also,
dissociation of HSP27 oligermers by phosphorylation
has been shown to stabilization F-actin and inhibit of
actin  degradation  (12).  This  evidence  suggests  that
phosphorylation  is  needed  for  HSP27  to  convey  a
protective  function.  Our  study  showed  that
Figure 1:  Graphs show the relative expression of HSP25, along with
the  corresponding  Western  Blots  in  control  dogs  (n=5)  versus A)
Ventricular tachypacing model of CHF (n=5), p= 0.7405 and B) ATP
(n=5), p=0.7728. Protein expression levels were unchanged in either
ATP or CHF models.
Figure 2: Western Blots and corresponding data showing the relative
expression  of  HSP70  in  control  dogs  (n=5)  versus A)  Ventricular
tachypacing  model  of  CHF  (n=5),  p=  0.8874  and  B) ATP  (n=5),
p=0.4597.Protein expression level were unchanged in either ATP of
CHF models.Heat Shock Proteins 37 Vol. 12  No. 2
phosphorylation of at least one serine residue (ser-78) is
significantly  decreased  in  the  canine  model  of  CHF.
Although the phosphorylation of HSP27 also tended to
be  decreased  in  the  ATP  group,  these  effects  were
inconsistent between samples and might be attributed to
individual  variations  between  the  canine  subjects.
According to the results in our current study, it could be
inferred that during sustained periods of AF-promoting
conditions, endogenous HSP27 is unlikely to convey a
protective  effect.  Decreased  phosphorylation  would
hinder the cytoprotective role of HSP27 and allow for
atrial  remodeling,  thus  promoting  AF  maintenance.
However, other studies have shown that large oligomers
of  HSP27  are  necessary  for  it  to  exhibit  chaperone
functions,  and  that  phosphorylation  causes  a
dissociation of HSP27 into tetramers, which is not an
effective  chaperone  (12).  Therefore,  a  decrease  in
phosphorylation,  as  seen  in  this  present  study,  could
allow for HSP27 to act as a better chaperone in the
cytoplasm  and  provide  resistance  against  stress.  The
findings  that  non-phosphorylated  HSP27  oligomers
confer  resistance  to  the  cytotoxic  effects  of  H2O2,
manadione,  and  TNFα,  and  that  phosphorylated
mutants of HSP27 convey less of a protective function
supports this claim (13). 
It  is  widely  acknowledged  that  HSP27  and  other
chaperone proteins are cytoprotective during conditions
of stress. However, it is apparent that there is not yet a
clear mechanism as to how the phosphorylation status
of HSP27 affects its protective function. In our study,
we  had  a  statistically  significant  decrease  in
phosphorylation in the CHF model of AF. According to
our current understanding of HSP27 phosphorylation,
as discussed above, these results can be interpreted in
two  contrasting  ways:  1)  the  observed  decrease  in
phosphorylation,  and  thus  a  decrease  in  HSP27’s
protective  function,  allows  for  atrial  remodeling  and
therefore the maintenance of AF, or 2) the decreased
phosphorylation is in fact a protective mechanism and is
an attempt to counteract the AF promoting conditions
and prevent remodeling. 
Our  data  clearly  indicates  that  phosphorylation  of
HSP27  has  a  role  in  the  pathophysiology  of  AF,
however,  according  to  current  knowledge,  it  is
impossible  to  say  whether  this  change  is  harmful  or
beneficial. Since this study was not designed to resolve
this discrepancy, more research is obviously necessary
to  determine  which  of  these  two  contrasting
mechanisms is involved in the pathophysiology of AF. 
Contrary to data collected from earlier studies using
human atrial samples, we failed to detect any change in
the level of expression of various HSPs in two canine
models of AF. For example, our study found that there
was no change in expression of HSP25 (an ortholog of
HSP27) while a limited study by Yang et al. detected a
trend,  which  did  not  reach  significance,  towards  an
increase in HSP27 expression in 17 patients with AF,
compared to 7 in SR, and concluded that HSP27 may be
associated  with  different  stages  of  AF  (7).  Similar
results were also reported by Brundel et al. who found
Figure 3: Western Blots and corresponding data showing the relative
expression  of  HSP90  in  control  dogs  (n=5)  versus A)  Ventricular
tachypacing  model  of  CHF  (n=5),  p=  0.2155  and  B) ATP  (n=5),
p=0.4630. Protein expression levels were unchanged in either ATP or
CHF models.
Figure 4: Western Blots and corresponding data showing the relative
levels  of  phosphorylated  HSP27  (ser-78)  in  control  dogs  (n=5)
compared to the ATP group (n=5), p=0.0923, and the CHF group
(n=5), p=0.0111. *P<0.0538 McGill Journal of Medicine 2009
that  HSP27  levels  were  significantly  increased  in
patients with paroxysmal AF compared to patients in
SR and with persistent AF (5). The conclusion reached
by their study was that increased levels of Hsp27 may
protect against myolysis and slow the progression to
persistent AF.  It should be noted that human studies,
especially with a small sample size, do not allow for the
same degree of control and reproducibility as animal
models. The pathophysiology of AF is complex, and the
duration  and  severity  can  vary  widely  between
individuals, which would make data unreliable in small
sample sizes. Differences between these earlier human
studies and our current study could also be the result of
other factors including species variations since unlike
the  former;  this  study  involved  the  use  of  two  well
established canine models. It should also be noted that
the canine subjects were not screened for underlying
cardiac conditions which may have also contributed to
some  of  the  observed  variations  detected  between
individual  samples.  Therefore,  the  use  of  a  canine
model  is  able  to  limit,  but  not  entirely  eliminate,
intersubject  variability.  Since  using  animal  models
allows  for  a  greater  degree  of  control  and
reproducibility,  the  results  from  this  study  are  more
reliable compared to those from human studies with a
small sample size. To resolve the differences between
the  human  studies  and  our  in  vivo canine  models,
further  studies  investigating  the  expression  of  HSPs
during AF are warranted.
CONClUSION 
Research  shows  that  HSPs  have  a  role  in  the
pathophysiology of atrial fibrillation. Although our data
shows that the expression levels of HSPs may remain
constant,  we  demonstrate  that  there  are  protein
phosphorylation  and  dephosphorylation  events  that
occur in AF that may have important consequences in
its pathophysiology. In the case of HSP27, we detected
a significant decrease in its phosphorylation in a canine
model  of  CHF.  Also  note  that  other  HSPs  such  as
HSP70 and HSP90 are known to be involved in protein-
protein  interactions  and  are  modified  under  various
physiological  conditions  (14).  Therefore,  this  study
provides  important  evidence  that  requires  further
investigation into HSP post-translational modifications
and protein-protein interactions in AF and its relevance
to  the  pathophysiology  of  this  condition.    It  will  be
necessary  to  investigate  the  full  scale  of  HSP
modifications during AF and AF-promoting conditions.
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